Search research articles
Contact Us
Filters
Showing results (71-80 of 180) with videos related to
Page
of 18
Sort By:
Cancer Chemotherapy and Pharmacology
|
May 19, 2011
Factors affecting the pharmacokinetics of pegylated liposomal doxorubicin in patients
Ninh M La-Beck, Beth A Zamboni, Alberto Gabizon, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
March 6, 2007
Effect of moderate aerobic exercise on sympatho-vagal balance in Type 2 diabetic patients
G Zoppini, V Cacciatori, M L Gemma, et al.
Annals of the New York Academy of Sciences
|
December 13, 1996
Schedule-dependent efficacy of camptothecins in models of human cancer
P J Houghton, C F Stewart, W C Zamboni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 14, 1998
Phenytoin alters the disposition of topotecan and N-desmethyl topotecan in a patient with medulloblastoma
W C Zamboni, A J Gajjar, R L Heideman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 21, 1998
Phase I study of topotecan in combination with cyclophosphamide in pediatric patients with malignant solid tumors: a Pediatric Oncology Group Study
R L Saylors, C F Stewart, W C Zamboni, et al.
Pharmacotherapy
|
October 18, 2000
Pharmacokinetics of gemcitabine and 2',2'-difluorodeoxyuridine in a patient with ascites
B J Delauter, R K Ramanathan, M J Egorin, et al.
Antibodies (Basel, Switzerland)
|
September 24, 2019
Factors Affecting the Pharmacology of Antibody-Drug Conjugates
Andrew T Lucas, Lauren S L Price, Allison N Schorzman, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine
|
August 9, 2019
Pretargeted delivery of PEG-coated drug carriers to breast tumors using multivalent, bispecific antibody against polyethylene glycol and HER2
Christina L Parker, Morgan D McSweeney, Andrew T Lucas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 16, 2001
The effect of increasing topotecan infusion from 30 minutes to 4 hours on the duration of exposure in cerebrospinal fluid
W C Zamboni, D I Lüftner, M J Egorin, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine
|
October 11, 2016
Profiling the relationship between tumor-associated macrophages and pharmacokinetics of liposomal agents in preclinical murine models
Andrew T Lucas, Taylor F White, Allison M Deal, et al.
Page
of 18
Search research articles
Search
Showing results (71-80 of 180) with videos related to
Sort By:
Page
of 18
Cancer Chemotherapy and Pharmacology
|
May 19, 2011
Factors affecting the pharmacokinetics of pegylated liposomal doxorubicin in patients
Ninh M La-Beck, Beth A Zamboni, Alberto Gabizon, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
March 6, 2007
Effect of moderate aerobic exercise on sympatho-vagal balance in Type 2 diabetic patients
G Zoppini, V Cacciatori, M L Gemma, et al.
Annals of the New York Academy of Sciences
|
December 13, 1996
Schedule-dependent efficacy of camptothecins in models of human cancer
P J Houghton, C F Stewart, W C Zamboni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 14, 1998
Phenytoin alters the disposition of topotecan and N-desmethyl topotecan in a patient with medulloblastoma
W C Zamboni, A J Gajjar, R L Heideman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 21, 1998
Phase I study of topotecan in combination with cyclophosphamide in pediatric patients with malignant solid tumors: a Pediatric Oncology Group Study
R L Saylors, C F Stewart, W C Zamboni, et al.
Pharmacotherapy
|
October 18, 2000
Pharmacokinetics of gemcitabine and 2',2'-difluorodeoxyuridine in a patient with ascites
B J Delauter, R K Ramanathan, M J Egorin, et al.
Antibodies (Basel, Switzerland)
|
September 24, 2019
Factors Affecting the Pharmacology of Antibody-Drug Conjugates
Andrew T Lucas, Lauren S L Price, Allison N Schorzman, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine
|
August 9, 2019
Pretargeted delivery of PEG-coated drug carriers to breast tumors using multivalent, bispecific antibody against polyethylene glycol and HER2
Christina L Parker, Morgan D McSweeney, Andrew T Lucas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 16, 2001
The effect of increasing topotecan infusion from 30 minutes to 4 hours on the duration of exposure in cerebrospinal fluid
W C Zamboni, D I Lüftner, M J Egorin, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine
|
October 11, 2016
Profiling the relationship between tumor-associated macrophages and pharmacokinetics of liposomal agents in preclinical murine models
Andrew T Lucas, Taylor F White, Allison M Deal, et al.
Page
of 18